Skip to main content
$28.75 $0.04 (0.1%)

04:00 PM EDT on 09/17/21

Iteos Therapeutics (NASDAQ:ITOS)

CAPS Rating: No stars

Current Price $28.75 Mkt Cap $1.0B
Open $28.50 P/E Ratio 0.00
Prev. Close $28.75 Div. (Yield) $0.00 (0.0%)
Daily Range $27.87 - $29.11 Volume 522,892
52-Wk Range $17.43 - $47.61 Avg. Daily Vol. 179,076

Caps

How do you think NASDAQ:ITOS will perform against the market?

Add Stock to CAPS Watchlist

All Players

3 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITOS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:ITOS VS S&P 500 (SPY)

NASDAQ:ITOS Summary

Fools bullish on NASDAQ:ITOS are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about ITOS.

Recs

0
Member Avatar BamaFool72 (< 20) Submitted: 2/9/2021 12:21:08 PM : Outperform Start Price: $40.12 NASDAQ:ITOS Score: -41.10

I also love the prospects for this company.

Recs

0
Member Avatar CMFMLove (77.83) Submitted: 2/9/2021 10:22:12 AM : Outperform Start Price: $39.80 NASDAQ:ITOS Score: -40.63

Iteos Therapeutics, Inc is a small cap company focused on the development of biopharmaceuticals products and services. Iteos presently has two clinical-stage product candidates, Inupadenant (EOS-850) and EOS-448. Inupadenant targets the ATP adenosine pathway, while EOS-448 targets TIGIT (T cell immunoreceptor with immunoglobulin and ITIM domains). Anti-TIGIT is the next wave in oncology treatments and Iteos is one of the leaders. I think it will pay off big.

Leaderboard

Find the members with the highest scoring picks in ITOS.

Score Leader

cruisin25

cruisin25 (61.54) Score: +5.55

The Score Leader is the player with the highest score across all their picks in ITOS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
cruisin25 61.54 6/16/2021 Outperform 3M $26.36 +9.73% +4.19% +5.55 0 Comment
CMFMLove 77.83 2/9/2021 Outperform 5Y $39.80 -27.34% +13.29% -40.63 1 Comment
BamaFool72 < 20 2/9/2021 Outperform 5Y $40.12 -27.92% +13.19% -41.10 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITOS.